GlassScriptPhysician profile
Gregory Keith Bruce
NPI 1306814520
$2,873.80
in general payments reported to CMS, 2019-2025
14 companies · $76.52 in 2025
The $76.52 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $11.74 · 2021: $63.32 · 2022: $672 · 2023: $1,386 · 2024: $496 · 2025: $76.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,698 · Consulting Fee: $158 · Travel and Lodging: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,697.76 |
| Consulting Fee | $157.50 |
| Travel and Lodging | $103.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $593.78 | 2019-2024 | Aveir, Jot Dx, Mitraclip |
| Medtronic, INC. | $493.06 | 2023-2024 | Micra |
| Atricure, INC. | $399.10 | 2022-2024 | |
| Irhythm Technologies, INC. | $309.38 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Biosense Webster, INC. | $269.17 | 2022-2024 | Carto 3 |
| Medical Device Business Services, INC. | $231.99 | 2022 | |
| Zoll Respicardia, INC. | $180.94 | 2023-2024 | Remede System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $151.37 | 2021-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $121.96 | 2019 | |
| Boston Scientific Corporation | $58.06 | 2025 | Farapulse |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.81 | 2021 | |
| Pfizer INC. | $18.46 | 2025 | |
| Baylis Medical Company INC | $11.98 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bruce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.